From owner-chromosomes@net.bio.net Sun Nov 03 22:00:00 1996
Message-ID: <327DF025.5CE8@uni-konstanz.de>
Date: Mon, 04 Nov 1996 14:31:17 +0100
From: Bernd Langkau <bernd.langkau@uni-konstanz.de>
Reply-To: bernd.langkau@uni-konstanz.de
Organization: University of Constance
X-Mailer: Mozilla 3.0Gold (Win95; I)
MIME-Version: 1.0
Newsgroups: bionet.genome.chromosomes
CC: Bernd.Langkau, Thomas.Seebacher
Subject: Molbio-Software (Macintosh)
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
NNTP-Posting-Host: toprope.verwaltung.uni-konstanz.de
Lines: 7
Path: biosci!agate!howland.erols.net!newsfeed.internetmci.com!mr.net!newshub.tc.umn.edu!fu-berlin.de!news.belwue.de!news.uni-konstanz.de!toprope.verwaltung.uni-konstanz.de

A new program for the evaluation of gel images is available from
http://www.uni-konstanz.de/tt/software/mwmacro.html or from
ftp://ftp.uni-konstanz.de/pub/local/Biologie/MW-Macro.sea.bin. 

The new shareware program (50.-DM) calculates molecular weights,
pI-values and band intensities from scanned gel images. The program
requires Macintosh computers and NIH-Image software.

From owner-chromosomes@net.bio.net Sun Nov 03 22:00:00 1996
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.erols.net!EU.net!sun4nl!wirehub!news.euro.net!xs4all!news.unisource.nl!ns1.att.nl!surfnet.nl!Hermes.nki.nl!Hermes.nki.nl!twezel
From: Tom van Wezel <twezel@nki.nl>
Newsgroups: bionet.genome.chromosomes
Subject: postdoc position available
Date: Mon, 4 Nov 1996 14:48:19 +0000
Organization: Netherlands Cancer Institute, Amsterdam
Lines: 42
Message-ID: <Pine.SOL.3.95.961104144517.11813B-100000@Hermes.nki.nl>
NNTP-Posting-Host: mercurius.nki.nl
Mime-Version: 1.0
Content-Type: TEXT/PLAIN; charset=US-ASCII

POSTDOCTORAL POSITION

is available at The Netherlands Cancer Institute in Amsterdam for 2 to 3
years. It is open for citizens or residents of countries of the European
Union (excluding the 
Netherlands)  to carry out research on 

SUSCEPTIBILITY GENES FOR LUNG AND INTESTINAL CANCER 

In the past two years, we mapped several novel genes controlling
susceptibility to lung and intestinal tumors in the mouse. Most of these
genes appear to be different from the presently known oncogenes, tumor
suppressor genes, and mismatch repair genes and may be involved in
cellular signalling and regulation of differentiation. 
The aim of the project is to use molecular and biological approaches to
study the biological effects of these genes, their mutual interactions,
their effects on tumorigenesis in different tissues, as well as their
possible effect on the action of oncogenes and tumor suppressor genes.
Molecular and genetic techniques will be applied towards positional
cloning of selected members of this  group of genes and to study their
possible interactions with the oncogenes or their role in signalling
pathways.
The Institute has a broad multidisciplinary basis for cancer research with
groups  carrying out advanced research in the fields of molecular
genetics, immunology, cellular biology, and signal transduction.


The candidates should possess a Ph.D. degree and have active interest in
molecular genetics and tumor biology. 
Qualified investigators interested in this position can contact Dr. P.
Demant 
(tel. +31 20 5121992, fax +31 20 5122011, 

e-mail demant@nki.nl).

Applications should be sent to:
The Netherlands Cancer Institute,
Personnel Department, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.
The letter should have the reference nr. 95-245.




From owner-chromosomes@net.bio.net Mon Nov 04 22:00:00 1996
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!in1.uu.net!ott.istar!istar.net!tor.istar!east.istar!news1.istar.ca!news
From: awebster@magi.com (Al Webster)
Newsgroups: bionet.genome.chromosomes
Subject: 4q-
Date: 5 Nov 1996 22:12:58 GMT
Organization: iSTAR Internet Incorporated
Lines: 2
Message-ID: <55oe5a$cqj@news.istar.ca>
NNTP-Posting-Host: ts25-15.ott.istar.ca
X-Newsreader: Forte Free Agent 1.0.82

Does anyone have info on this chromosome deletion?


From owner-chromosomes@net.bio.net Tue Nov 05 22:00:00 1996
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.erols.net!newsxfer2.itd.umich.edu!bloom-beacon.mit.edu!senator-bedfellow.mit.edu!lester
From: lester@genome.wi.mit.edu (Lester Hui)
Newsgroups: bionet.genome.chromosomes
Subject: [REPOST] WHITEHEAD/MIT HUMAN PHYSICAL MAP, RELEASE 11
Date: 6 Nov 1996 18:27:22 GMT
Organization: Whitehead Institute for Biological Research
Lines: 103
Message-ID: <55qlaa$31v@senator-bedfellow.MIT.EDU>
NNTP-Posting-Host: tango.wi.mit.edu

Sorry to those seeing this message twice.  It has been brought to
my attention that some news feeds to not post this message the first
time.

                         ANNOUNCING:
      WHITEHEAD INSTITUTE/MIT CENTER FOR GENOME RESEARCH
               HUMAN GENOMIC MAPPING PROJECT 
                 DATA RELEASE 11 (OCTOBER 1996)


The eleventh release of data from the Human Physical Mapping
Project at the Whitehead Institute/MIT Genome Center, covering data
generated through the end of October, 1996, is now available.

This data release contains YAC screening data for 22,582 sequence
tagged sites (STSs) screened on the CEPH mega-YAC library.  For each
STS, we report addresses for the YACs found to contain the STS. The
data assemble into 292 contigs using single linkage between STSs.

In addition, we also report a radiation hybrid map of the genome
containing 12508 STS markers mapped on the Genebridge Panel, as well
as integrations of the genetic, radiation hybrid and YAC contig maps.
The map includes data from over 10000 expressed sequences, part of the
transcript map published in Science 25 October 1996.

The data is available electronically in two ways.

ANONYMOUS FTP: The entire data release is available as a set of
Microsoft Excel files and tab-delimited ascii files on our ftp
server.  Using an ftp client (such as "Fetch" on the Macintosh),
connect to 

	ftp-genome.wi.mit.edu

Use "anonymous" as your user name, and give your e-mail address as
your password.  The data files are present in the directory
/distribution/human_STS_releases/oct96.

The contents are as follows:

  10-96.INTRO.txt        Introduction to the data release, in straight text format
  10-96.INTRO.html       The same in HTML (World Wide Web) format
  10-96.STS.DATA.txt     STS mapping data as tab-delimited text.
  chromosomes/           The same, split into smaller chromosome-specific files
  10-96.YAC2STS.txt      Inverse map of YAC to STS screening data
  10-96.CONTIG2STS.txt   YAC contig lists.
  10-96.CONTIG2STS.txt   The same, inverted.
  10-96.SEQUENCES.txt    Full sequences of STSs developed in-house.
  10-96.MAPPED.EST.txt   Cross reference between ESTs, IMAGE clones and map positions.
  10-96.ALIASES.txt      Cross reference of STS names.
  pictures/              Pictures of integrated maps in Macintosh and PS forms.
  rhmap/                 Radiation hybrid maps.
  genmap/                Genethon genetic linkage maps.

The data is also available in compressed form using the gzip program.

THE WORLD-WIDE WEB: You will need a World Wide Web client such as
Mosaic (Unix, MS-Windows and Macintosh) or MacWeb (Macintosh). 
Instruct your client to connect to 

      http://www.genome.wi.mit.edu/

From there, follow the "Human Physical Mapping Project" link.  You
will be able to browse and download the raw data set, view the
individual and integrated maps, and to get information on the
radiation hybrid and contig analyses.

All mapped STSs are available through the Genome Database (GDB) and
through GenBank.  Users interested in EST mapping are also referred to
the following URL:

	http://www.ncbi.nlm.nih.gov/Science96/

QUESTIONS AND PROBLEMS.  If users have any questions or problems,
please contact us at human_STS_help@genome.wi.mit.edu We invite
suggestions about how to make these data release most useful.

DATA RELEASE POLICY AND CITATION.  Data releases are scheduled
quarterly.  At the end of each quarter, all genomic mapping data are
reviewed and prepared for distribution via CGR's electronic databases.
Data releases typically occur within a week of the close of the
month. Releases are announced by electronic messages posted to the
following two newsgroups: "bionet.genome.chromosomes" and
"bionet.announce".

CGR's data release policy aims to ensure that scientific colleagues
have immediate access to information that may assist them in the
search for genes. Data releases do not constitute scientific
publication of CGR's work, but rather provide scientists with a
regular look into our lab notebooks.   For projects aimed at the
analysis of particular genes or subchromosomal regions, permission is
hereby granted to use our data without the need for a formal
collaboration, subject only to appropriate acknowledgment.   For
projects aimed at large-scale mapping of entire chromosomes or entire
genomes, use of the data and markers should be on a collaborative
basis.

The information for the human genome mapping project should be cited
as: Whitehead Institute/MIT Center for Genome Research, Human Physical
Mapping Project, Data Release 11 (October 1996).




From owner-chromosomes@net.bio.net Thu Nov 07 22:00:00 1996
Path: biosci!fcs280s.ncifcrf.gov!cpk-news-feed1.bbnplanet.com!news.bbnplanet.com!cpk-news-hub1.bbnplanet.com!www.nntp.primenet.com!nntp.primenet.com!feed1.news.erols.com!howland.erols.net!newsfeed.internetmci.com!newsbuffer.myriad.net!news.fibr.net!news.sprintlink.net!news-fw-22.sprintlink.net!news.gate.net!wthfl2-61.gate.net!pttc3
From: pttc3@gate.net (thomas m. clapp)
Newsgroups: bionet.genome.chromosomes
Subject: chromosomes
Date: Fri, 8 Nov 1996 14:21:28
Organization: CyberGate, Inc.
Lines: 5
Message-ID: <pttc3.4.000E5C09@gate.net>
NNTP-Posting-Host: wthfl2-61.gate.net
Keywords: klinefelter's sysdrome
X-Newsreader: Trumpet for Windows [Version 1.0 Rev A]

i am interested in finging out more info. on this sysdrome.  i have it and i 
am willing to give any details for any research.  i do a xxy chromosome.  of 
course i am a male with some of the characteristics of klinefelter's sysdrome.
e-mail:  pttc3@gate.net


From owner-chromosomes@net.bio.net Fri Nov 08 22:00:00 1996
Path: biosci!rutgers!uwm.edu!cs.utexas.edu!news.tamu.edu!news.mty.itesm.mx!NewsWatcher!user
From: al177663@academ01.mty.itesm.mx (Raymundo Sánchez)
Newsgroups: bionet.genome.chromosomes
Subject: Re: chromosomes
Date: Sat, 09 Nov 1996 12:49:52 -0600
Organization: ITESM
Lines: 26
Message-ID: <al177663-0911961249520001@131.178.80.79>
References: <pttc3.4.000E5C09@gate.net>
NNTP-Posting-Host: 131.178.80.79

In article <pttc3.4.000E5C09@gate.net>, pttc3@gate.net (thomas m. clapp) wrote:

> i am interested in finging out more info. on this sysdrome.  i have it and i 
> am willing to give any details for any research.  i do a xxy chromosome.  of 
> course i am a male with some of the characteristics of klinefelter's sysdrome.
> e-mail:  pttc3@gate.net

Hello, mi name is Raymundo Sanchez and I am interested in the
klinefelter's sysdrome, but unfurtunately, I am still studying my mayor at
the University,
so I think that I can´t do something to help you, but I would like to hear
more about this syndrome, the next semester I will begin my, " Diplomado "
in biotechnology, and I will take Genetic Ingeniering, I think that in the
class I will study, syndromes.

I am studying, my major ( carrear ) in Chemical Sciences, * I think that
this is  the tranduction from spanish to english *
I am at the ITESM, ( name of my shool ), here in Monterrey MEXICO,

I want to be excuse, because my english is not good, but I am doing, my
best,for 
do it better!!!

I hope to hear notice from you soon !!
my e-mail:  
            al177663@academ01.mty.itesm.mx

From owner-chromosomes@net.bio.net Sat Nov 09 22:00:00 1996
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.erols.net!news.sprintlink.net!news-stk-200.sprintlink.net!news.onramp.net!usenet
From: jwes@onramp.net (Dr. Larry)
Newsgroups: bionet.genome.chromosomes
Subject: Saethre-Chotcen Syndrome
Date: 10 Nov 1996 18:44:45 GMT
Organization: OnRamp Technologies; ISP;  Dallas/Ft Worth/Houston, TX USA
Lines: 10
Message-ID: <5657qt$sab@news.onramp.net>
NNTP-Posting-Host: lonestar21.onramp.net
Mime-Version: 1.0
Content-Type: Text/Plain; charset=US-ASCII
X-Newsreader: WinVN 0.99.8 (beta 2)

I am currrently doing educational planning for a eight year old, male with the 
diagnosis of Saethre-Chotcen Syndrome. The child is marginally retarded with 
some behavior problems. I am looking for sources regarding the syndrome and its 
implications. I have only been able to gleen the most basic of information 
generally in the area of facial, skelletial abnorminalities. Any help would be 
appreciated.

Dr. Larry Westmoreland
Fort Worth, Texas


From owner-chromosomes@net.bio.net Sat Nov 09 22:00:00 1996
Path: biosci!bloom-beacon.mit.edu!panix!feed1.news.erols.com!howland.erols.net!news.sprintlink.net!news-stk-200.sprintlink.net!news.onramp.net!usenet
From: jwes@onramp.net (Dr. Larry)
Newsgroups: bionet.genome.chromosomes
Subject: Saethre-Chotcen Syndrome
Date: 10 Nov 1996 18:47:15 GMT
Organization: OnRamp Technologies; ISP;  Dallas/Ft Worth/Houston, TX USA
Lines: 10
Message-ID: <5657vj$sin@news.onramp.net>
NNTP-Posting-Host: lonestar21.onramp.net
Mime-Version: 1.0
Content-Type: Text/Plain; charset=US-ASCII
X-Newsreader: WinVN 0.99.8 (beta 2)

I am currrently doing educational planning for a eight year old, male with the 
diagnosis of Saethre-Chotcen Syndrome. The child is marginally retarded with 
some behavior problems. I am looking for sources regarding the syndrome and its 
implications. I have only been able to gleen the most basic of information 
generally in the area of facial, skelletial abnorminalities. Any help would be 
appreciated.

Dr. Larry Westmoreland
Fort Worth, Texas


From owner-chromosomes@net.bio.net Sun Nov 10 22:00:00 1996
Path: biosci!agate!howland.erols.net!www.nntp.primenet.com!nntp.primenet.com!nntp.uio.no!nntp.uib.no!nntp-bergen.UNINETT.no!nntp-trd.UNINETT.no!daresbury!lyra.csx.cam.ac.uk!news
From: ricky critcher <rc@mole.bio.cam.ac.uk>
Newsgroups: bionet.genome.chromosomes
Subject: FISH on blood smears
Date: Mon, 11 Nov 1996 14:22:21 +0000
Organization: University of Cambridge, England
Lines: 12
Message-ID: <3287369C.5953@mole.bio.cam.ac.uk>
Reply-To: rc@mole, bio.cam.ac.uk
NNTP-Posting-Host: png-mac8.gen.cam.ac.uk
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 3.0 (Macintosh; I; 68K)

Hi

I am trying to FISH yacs onto mouse peripheral blood smears but so far
have had no success. Does any one out there have some handy hints. Any
help would be greatly appreciated.

Thanks 

Ricky Critcher
Dept. of Genetics
Cambridge University
UK

From owner-chromosomes@net.bio.net Mon Nov 11 22:00:00 1996
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.erols.net!swrinde!news.uh.edu!rpenny
From: rpenny@Bayou.UH.EDU (Riggs Penny)
Newsgroups: bionet.genome.chromosomes
Subject: Re: FISH on blood smears
Date: 12 Nov 1996 22:13:19 GMT
Organization: University of Houston
Lines: 23
Message-ID: <56aspv$atk@Masala.CC.UH.EDU>
References: <3287369C.5953@mole.bio.cam.ac.uk>
NNTP-Posting-Host: bayou.uh.edu
X-Newsreader: TIN [version 1.2 PL2]

ricky critcher (rc@mole.bio.cam.ac.uk) wrote:


: I am trying to FISH yacs onto mouse peripheral blood smears but so far
: have had no success. Does any one out there have some handy hints. Any
: help would be greatly appreciated.

Try treating the blood sample with 0.75M KCl for 10 min, centrifuge
and remove most of the supernatant, then make a "smear" with a few
drops of the remaining liquid/pellet.  This method will allow you
to get rid of most of the red blood cells so you can hybridize to
the remaining leucocyte nuclei.

Penny Riggs
                                      NASA LB Johnson Space Center 
rpenny@bayou.uh.edu                   Mail Code SD2
http://www.sss.org/~penny             Houston, TX 77058







From owner-chromosomes@net.bio.net Tue Nov 12 22:00:00 1996
Newsgroups: bionet.genome.chromosomes
Path: biosci!agate!howland.erols.net!newsfeed.internetmci.com!malgudi.oar.net!utnetw!mabrini
From: mabrini@uoft03.utoledo.edu (Pan Parag)
Subject: Look here!
Message-ID: <E0s3zq.2Ew@utnetw.utoledo.edu>
Sender: news@utnetw.utoledo.edu (News Manager)
X-Newsreader: TIN [version 1.2 PL2]
Date: Tue, 12 Nov 1996 22:33:26 GMT
Lines: 1



From owner-chromosomes@net.bio.net Wed Nov 13 22:00:00 1996
Path: biosci!rutgers!uwm.edu!www.nntp.primenet.com!nntp.primenet.com!howland.erols.net!portc02.blue.aol.com!portc01.blue.aol.com!audrey01.news.aol.com!not-for-mail
From: smacker5@aol.com
Newsgroups: bionet.genome.chromosomes
Subject: partial monosomy chromosome 7
Date: 14 Nov 1996 21:31:13 GMT
Organization: AOL http://www.aol.com
Lines: 55
Sender: news@aol.com
Message-ID: <19961114213300.QAA01866@ladder01.news.aol.com>
NNTP-Posting-Host: ladder01.news.aol.com

To whom it may concern;

I am a parent of a 15 month girl named Jessica. She was born with a
segment deletion of the long arm chromosome 7. The genotype is: 46,XX,del
(7)(q22.1q31.2). Since receiving the results we have been informed that
her particular situation is rare, and only 7 other children since 1976
have been reported with it. The reports of the seven children are extreme,
which gives me reason for great concern. My daughter displays low muscle
tone, and a delay in development. She has been described as, mild global
hypotonia involving both axial and appendicular muscles: mild hypotonia is
noted in the region of pelvic girdle.To date, her gross motor is about 2.5
months behind, and her fine motor and cognative skills are right on
target. The span for gross and fine motor was 6-7 months behind when
physical and occupational therapy began. There are no concerns about
regression in any of the devepmental parameters at this time Since birth,
her index fingers on both hands have been described as arthrogrypotic.
They have always been flexed or curled in toward her palms. She has been
using them more, but still displays an immature pincer grasp. Jessica has
had a MRI, which has ensured us of normal structure of her brain. The
various blood tests have also been normal except the chromosomes.

She recently has seen Dr. Hutcheon, chief section of genetics at St. Joe's
in Paterson NJ. He told us, when reading the reports, he did not feel very
optimistic about her condition. But, after Dr. Hutcheon met Jessica, he
was relieved, and feels very optimistic of her future. He concurred that
Jessica's phenotype is less severe than the seven children in the
scientific literature we have received. However, he did tell us we should
expect some sort of learning disability in the future, but obviously can
not tell to what degree. I was wondering if I could take my research
further to talk with a scientist who may be studying this so called
syndrome. I am not sure how to go about doing so. If you have any
suggestions I would be most appreciative. He also mentioned the fact that
the other part of her chromosome 7 is in tact, and all information is
there. Does this mean that her condition will not be as severe? 

What is involved with having my daughter studied. Is this something that
is possible, and should I consider it at all. I feel it is important for
Jessica to be studied, and entered into the report with the other seven
children. This would show there are degrees of symptoms and hope for the
next parent reading that report. I am still trying to track down a current
report on the seven children. Some must be around 17 or 18 and even 20 by
now. Have they gone to college, do they live "normal" lives etc. As you
can see I'm still looking for information, as well as, what else can I do
for my daughter. The doctors all say the best thing I could have done was
to get her involved in physical & occupational therapies very early. It
has helped her tremendously, but what can I do for her possible learning
disabilities. If you have any suggestions I am very willing to hear them,
as well as reaserch them on the internet. Is there a way to find out of an
ongoing study of this genotype? Thank-you so much for any information you
can provide.

Sincerely,
Lori Dring
E-mail: Smacker 5


From owner-chromosomes@net.bio.net Thu Nov 14 22:00:00 1996
Path: biosci!bcm.tmc.edu!cs.utexas.edu!swrinde!www.nntp.primenet.com!nntp.primenet.com!feed1.news.erols.com!uunet!in1.uu.net!news-in.tiac.net!posterchild!news@tiac.net
From: Property Digest <propdig@barryinc.com>
Newsgroups: bionet.genome.chromosomes
Subject: NATIONAL BIOTECH REGISTER
Date: Fri, 15 Nov 1996 10:13:50 -0800
Organization: U.S. Real Estate Register
Lines: 5
Message-ID: <328CB2DE.6D1E@barryinc.com>
NNTP-Posting-Host: p10.ts6.lowel.ma.tiac.com
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 2.01 (Win16; I)

National Biotech Register announces a new service on our Web site, 
Supplier Provider. You can now look up a list of suppliers on NatBio's 
Web site by product classification. To learn more about this service and 
how to get your company listed, visit our site at: 
  http://www.barryinc.com/bio  or e-mail us at: natbio@barryinc.com..

From owner-chromosomes@net.bio.net Thu Nov 14 22:00:00 1996
Path: biosci!rutgers!gatech!csulb.edu!hammer.uoregon.edu!arclight.uoregon.edu!news.sprintlink.net!news-peer.sprintlink.net!EU.net!Austria.EU.net!01-newsfeed.univie.ac.at!swidir.switch.ch!in2p3.fr!univ-lyon1.fr!news.imag.fr!ciril.fr!usenet
From: Robert BRIMEYER <brimeyer@plg.u-nancy.fr>
Newsgroups: bionet.genome.chromosomes
Subject: Seckel syndrom (bird-headed)
Date: Fri, 15 Nov 1996 15:51:54 +0100
Organization: Universite de Nancy 2 - UFR MathInfo (IUP Miage)
Lines: 12
Message-ID: <328C838A.5CCB@plg.u-nancy.fr>
NNTP-Posting-Host: saphir.plg.u-nancy.fr
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 3.0 (X11; I; SunOS 5.5 sun4m)
CC: brimeyer@plg.u-nancy.fr

Dear Netters,

I`m looking for every kind of information about the SECKEL SYDROM (rare
genetic disease).
As a physiotherapist I have a patient (6 month old girl) who suffers
from this syndrom. 
What treatment may I offer... What is known about this syndrom (also
called bird-headed)

Thanks

Robert

From owner-chromosomes@net.bio.net Sat Nov 16 22:00:00 1996
Path: biosci!rutgers!uwm.edu!www.nntp.primenet.com!nntp.primenet.com!howland.erols.net!torn!news1.bellglobal.com!sunqbc.risq.net!news.risq.qc.ca!news.mcgill.ca!news
From: Graham Dellaire <popa0206@PO-Box.McGill.CA>
Newsgroups: bionet.genome.chromosomes
Subject: Call for VOTE: GENSTRUCTURE newsgroup bionet.genome.gene-structure
Date: 17 Nov 1996 18:56:57 GMT
Organization: McGill University Computing Centre
Lines: 300
Message-ID: <56nn5p$a5j@sifon.cc.mcgill.ca>
NNTP-Posting-Host: g-01.das.mcgill.ca
X-Newsreader: AIR News 3.X (SPRY, Inc.)

Voting is now open on the following proposal to create the mailing
list & newsgroup

GENSTRUCTURE/bionet.genome.gene-structure (moderated)

The charter was not modified as a result of the discussion.

*** NOTE *** We are often running several votes for other newsgroups,
so please be certain to follow the voting directions *carefully*! If
you just send in a message saying "YES" or "NO" it will not be counted
if it is not clear which proposal you are responding to.

----------------------------------------------------------------------
Proposal for GENSTRUCTURE/bionet.genome.gene-structure (moderated)

Proposed USENET name: bionet.genome.gene-structure

One line Description: Genome and chromatin structure and function

Status: Moderated

Proposed Moderation address: bionet-genome-gene-structure@net.bio.net
(genstruc-moderator@net.bio.net
is an alias for
bionet-genome-gene-structure@net.bio.net)

Moderator: Graham Dellaire

Proposed mailing list name: GENSTRUCTURE

Proposed e-mail addresses: genstruc@net.bio.net
genstruc@daresbury.ac.uk

Charter:

The purpose of the GENSTRUCTURE newsgroup is to provide a proper forum
for the discussion of issues pertaining and involving genome and/or
chromatin structure and function (see _Topics of Discussion_).
Primarily it should enable those researchers who work in
genome/chromatin structure or related fields to communicate ideas and
information, as well as, provide a chance for collaboration among
national and international research groups.

---------------------------------------------------------------------
Topics of Discussion include:

1. Genome/chromatin accessibility and recombination
-recombination hotspots (mieotic and mitotic)
-fragile sites
-imprinting and recombination rates
-ectopic gene targeting and chromatin structure

2. 3D-organization of the nucleus
-chromosome territories
-nucleoli
-nuclear lamina (telomere localization)
-tissue or cell cycle dependent
positioning of chromosomes
-RNA tracking

3. Effect of Superhelicity and DNA topology/structure(Triple strand,
Z-DNA,
cruciform, bent etc) on biological processes such as:
-replication 
(ex. replication fork barriers, initiation sites)
-transcription
(ex. promoter function in relation to superhelicity)
-recombination
(ex. Gin and Hin invertases and superhelicity)

4. Histones and Nucleosomes and chromatin structure/function
-H1 repression of transcription
-Post translational modification of histones
acetylation (H4, H3), phosphorylation (H1, H3)
and ubiquitination (H2A, H2B)
-Histone variants (ex. H2A.Z in mammals, H5 of chicken)

5. Models of genome structure (Loop Domain Model, Channel Model,
MegaBase Giant Loop Model, etc.)

6. Classical chromosome elements and their relationship to gene function
-centromeres (constitutive heterochromatin and 
gene silencing)
-telomeres (associated silencing and involvement
in position effect)

7. Evolution of the Genome
-isochores and base-content (GC vs. AT)
-formation of gene clusters and syntenic mapping
-repetitive elements (satellites, telomeric and
centromeric (alpha) repeats, lines and sines)

8. Biologically important mutants and knockouts that affect
genome/chromatin structure
-ex. SNF/SWI, TOPO mutants in yeast
-RAD 51,52,54 knockout mice
-AT, BLM, FA mouse models

9. Techniques for genome/chromatin analysis
-cytogenetic techniques (g banding, r and q)
-Fluorescent In situ analysis(FISH)
-Confocal microscopy
-Electron microscopy
-Electron microscopy In situ analysis (EMISH)
-psoralen, polyamine crosslinking
-In vivo nucleosome foot printing
-Dnase I/Micrococcal Nuclease sensitivity
-VM26 Topoisomerase II site mapping

10. Chromatin/DNA binding proteins and their effects on chromatin
structure
and/or gene expression
-Polycomb proteins
-Rap1 (telomere silencing)
-alpha2-MCM1 (repression of MAT locus)
-CENP A/B/C (centromere structure/function)
-XCAP-C/E, SMC1/2 (chromatin Condensation)
-remodeling of chromatin by SWI/SNF proteins
-H-NS in bacteria (role in nucleoid topology
vs. gene function)

11. Nuclear Matrix (NM) and Nuclear Lamina (NL)
-cell cycle regulation of formation of NM and NL
-transcription and replications factors 
and the concept of a dynamic NM 
(ex. tissue and temporal specificity) 
-role of NM in signal transduction
(mechanistic vs. chemical signals)

12. Matrix attatchent regions (MAR's), domain boundaries and locus
control regions (LCR's) and their relationship to gene structure
and function.
-definition of transcription/replication domains
-model systems ex. betaglobin (LCR) SCS/SCS' of
the Drosophila Heat Shock Locus (HS87a7)

13. Phenomenon of Position Effect and Transvection
-in drosophila (HP1, polycomb, heterochromatization)
-in mammalian systems (silencing or variegated
expression of transgenes)
-in fungi 

14. Epigenetic effects on gene function
-imprinting
-methylation
-maintenance of early/late replication

15. Dosage compensation mechanisms and X chromosome inactivation
-MSL proteins of Drosophila
-XIC (Xist RNA) in mammals
-CpG methylation

16. Chromatin structure and DNA replication
-ORC1 protein of yeast
-origins of replication 
(association with cruciform, bent DNA and MARS)

17. Specialized methods of nuclear packaging
-bacterial nucleoid
-packaging of DNA in spermatozoa

18. DNA repair and chromatin structure
-TFIIH (transcription coupled repair)
-p53
-BLM and AT genes
-poly-ADP-polymerase (PARP)

19. Mechanisms of genomic instability
-during oncogenesis
-process of chromosomal aberration (stable and unstable)
(ex. role of micronuclei in the process)
-chromosomal aberration during aging and mechanisms
of instability (ex. telomeres and telomerase)

In addition this newsgroup provides:

A forum for the exchange of information about future congresses
and meetings in areas of molecular biology relating to genome
structure/function.

A forum for the exchange of information about textbooks, internet
resources, visual materials, and computer programs.

A source of quick help for last-minute troubleshooting,
sources of materials, and practical advice; in areas such as
-Specific common resources
(ex. primers, antibodies, vectors)
-Genome analysis techniques
-Transgenic models and mutant cell lines

Moderation Policy:

Mass-posted commercial messages, chain letters, and similar postings
not associated with or pertaining to the study of genome/chromatin
structure and function will be deleted without comment. Inappropriate
messages posted in good faith will be returned to the sender.
Messages not strictly within the charter but likely to be of interest
to many subscribers (e.g., messages dealing with transcription and
replication factors) will be accepted.

Subscribers are welcome from universities or any academic
institutions, government agencies, medical institutions, and
industrial or commercial organizations. Contributions within the
functions outlined above are encouraged.


Proposed discussion leaders:

*Note: Area of expertise is written in brackets

Graham Dellaire, e-mail: dellaire@odyssee.net (gdella@po-box.mcgill.ca)
Institut du Cancer de Montreal
Centre de Recherche L.C. Simard
1560 Sherbrooke Street East,
Montreal, Quebec, Canada H2L 4M1
telephone:1 (514) 876 6936; fax: (514) 876 5476
*(Expertise:chromatin structure and recombination; Recombination
Access Mapping (RAM); genome structure analysis)

Ronald Hancock, e-mail: ronald.hancock@crhdq.ulaval.ca
Professor
Laval University Cancer Research Centre
1 rue de l'Arsenal
Quebec, Canada G1R 2J6
telephone: 1 (418) 691-5281; fax: 1 (418) 691-5439
*(Expertise:genome organisation in vivo; models of genome structure;
topoisomerases; VM26 topoisomerase II site mapping)

Eric Milot, e-mail: milot@ch1.fgg.eur.nl
Faculty of Medicine
Dept. of Cell Biology and Genetics
P.O. Box 1738
3000 DR Rotterdam
The Netherlands
telephone: 3110 4087164; fax: 3110 4360225
*(Expertise:Chromatin context and transcription; Polycomb
protein; position effect variegation; chromosome and nuclear
organisation; dosage compensation)

**Tentative Discussion leader**

Peter Cook, e-mail: peter.cook@pathology.oxford.ac.uk
Professor of Cell Biology,
The Sir William Dunn School of Pathology,
South Parks Road,
Oxford, OX1 3RE, UK.
Telephone (direct line) : +44/0 1865 275528
Telephone (switchboard) : +44/0 1865 275500
Fax : +44/0 1865 275501
http://www.molbiol.ox.ac.uk/www/users/counsell/cook.htm
(Expertise:Chromatin/Genome Structure and Function in regard to 
transcription and replication)
----------------------------------------------------------------------

Voting is now open on the proposal for
GENSTRUCTURE/bionet.genome.gene-structure and will run
through 24:00 hrs Pacific Time on 12 December 1996. Please send your
vote to either of the following addresses:

Address Location Network
------- -------- -------
biovote@daresbury.ac.uk U.K. JANET
biovote@net.bio.net U.S.A. Internet/BITNET

PLEASE BE SURE TO FOLLOW THE FORMAT BELOW - WE OFTEN RUN MORE THAN ONE
VOTE AT A TIME SO A SIMPLE "YES" OR "NO" MESSAGE WITHOUT THE NEWSGROUP
NAME MAY BE AMBIGUOUS. Your vote should contain a single line:

YES on GENES

if you favor allowing the creation of this newsgroup or

NO on GENES

if you think that this proposal will adversely affect the
BIOSCI/bionet system. While not intended to be an exhaustive list of
possible concerns (more specific concerns may have been raised during
the discussion period on BIOFORUM/bionet.general and interested
readers are referred to these), some general reasons for voting NO
might be if you are concerned about newsgroup proliferation and/or
believe that the proposed group will not be utilized, or if you think
that the proposed newsgroup would substantially duplicate or overlap
with the function of existing newsgroups. If you are simply not
interested in participating in the newsgroup above, please don't cast
a NO vote, but instead just don't vote at all.

The newsgroup proposal must receive at least 80 YES votes to pass and
the number of YES votes must be greater than the number of NO votes by
at least 40. Discussion of the newsgroup proposal is now closed and
we strongly discourage posting any messages in other forums about the
fact that a CALL FOR VOTES has been issued.

Sincerely,

Dave Kristofferson
BIOSCI/bionet Manager

biosci-help@net.bio.net



From owner-chromosomes@net.bio.net Sun Nov 17 22:00:00 1996
Path: biosci!agate!spool.mu.edu!uwm.edu!newsfeed.internetmci.com!nol.net!not-for-mail
From: Mark Peters <gquest@nol.net>
Newsgroups: bionet.genome.chromosomes
Subject: --> Cancer, Stealth Microbe
Date: Sun, 17 Nov 1996 20:22:24 -0800
Organization: GENIUS QUEST
Lines: 313
Message-ID: <328FE480.3623@nol.net>
Reply-To: gquest@nol.net
NNTP-Posting-Host: ip38-84.nol.net
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 3.0Gold (Win16; U)

STEALTH MICROBE CAUSES CANER


There are two basic forms of carcinogens (cancer causers):

EPIGENETIC -   carcinogens that  do not directly damage DNA but cause
alterations such as hormonal derangements, immunosuppression or chronic
tissue injury that in turn predisposes to cancer.

GENOTOXIC  -   Carcinogens that react directly with DNA or with
macromolucles that then react with DNA.

     The Stealth Microbe damages tissue by its presence, and alters
hormone balance, and causes immunosuppression .   The Stealth Microbe
can cause the formation of the carcinogen NMBA  by cell-mediated
catalysis. 
Also he Stealth Microbe secretes organic acids during carbohydrate
metabolism that can result in spontaneous nitrosation of the carcinogen
NMBA..  The Stealth Microbe is EPIGENETICALLY AND GENOTOXICALLY
CARCINOGENIC.


The rest of this document will be dedicated to medical research
that supports the statement that the stealth microbe causes
Cancer.


1980    Studies of a population with a high incidence of esophageal
carcinoma
showed that Stealth Microbe invasion was common in the esophageal
epithelium of patients with either premalignant changes or early
esophageal
carcinoma.  Nitrate and Nitrite were present in high concentrations in
the
water and staple grains.  This study established the ability of the
Stealth
Microbe to augment the nitrosative formation of the esophagus - specific
carcinogen benzylmethylnitrosamine (NBMA; N-nitroso-N-
methylbenzylamine).  Results showed that when there were more microbes
there was also more NBMA. Spontaneous nitrosation of BMA  was enhanced
under the acidic condidtions resulting from the acids secreted by the
Stealth
Microbe during Carbohydrate Metabolism.  Thus, the Stealth Microbe
invasion
into the epithelium could cause local formation of NBMA by both cell-
mediated catalysis and extracellular decreases in pH.

1987    From twelve cases of precancerous lesions, 21 strains of the
Stealth
Microbe were isolated belonging to 15 different biotypes.  Stealth
Microbes
obtained via biopsy were accessed for their ability to catalyze N-
nitrosobenzylmethylamine (NBMA) N-benylmethylamine and nitrite.  Strains
with the higher niltrosation potential were generally isolated from
lesions with
the more advanced precancerous changes.  This evidence supports the
hypothesis that the Stealth Microbe plays a causal role in the
development of
cancer, by means of endogenous nitrosamine production.  The microbe is
able to secrete organic acids during carbohydrate metabolism which
decreases the local pH and this results in a considerable increase in
the
microbes production of the carcinogen NBMA.

1994   "The study was aimed at determination of possible connection
between
co-existing S.M. infection in patients with lungcarcinoma with course of
neoplastic disease and ability to achieveremission by application of
different
methods of treatment. Thestudy involved 25 patients with histologically
confirmed lung carcinoma. Their sputum and bronchial rinsings were
tested.
The tests were performed at the moment of diagnosisof the
diseases, during and after treatment. In all patients so occurrence and
type of
S.M. infections was investigated  .Dynamics of  S.M.  infection was
measured by a scale from minimal to very severe. In about 1/3 of
patients at
the moment of diagnosisof the disease, severe or very severe infection
was
seen which was dependent of stage of the disease advancement. These
preliminary studies seem to indicate that presence of severe or very
severe S.M  infection is not favorable prognostically and frequently
correlates
with a progress of neoplastic changes and worse responseto treatment."


1994  Patients with malignancies are at high risk to develop systemic
non bacterial
infections. Stealth Microbe  accounts for approximately 80% of these
isolates.
The vast majority of these infections are of endogenous origin."

HOST DEFENSES AND HOW Stealth Microbe DEFEATS THEM  
     The skin and mucous membranes are primary
defenses                    
          Stealth Microbe attacks and eats the skin 
     The mucous membranes are primary
defense                              
          Proteinase attacks secretory IgA of mucous membranes 
          Gliotoxin attacks mucociliary action 
     Macrophages protect the respiratory
tract                             
          Gliotoxin inhibits macrophage phagocytosis 
     Cell mediated immunity protects us from Stealth
Microbe               
            Antigen processing 
            Macrophage activation 
          (3a) Inhibited lymphokine production 
          (3b) Inhibited activation of T lymphocytes 
     Myeloperoxidase enzyme protects against
mycoses                       
          Mannan inhibits myeloperoxidase release 
     Phagocytic cells are the mainstay of cellular
immunity                
          Stealth Microbe  grows from phagocytic cells 
          Antiphagocytic compound 
                           
     Humoral immunity: opsonization helps protect us           
          Proteinase reduces opsonizing activity 
    
     Humoral immunity: complement C3 role in host
defense                  
          Proteinase degradation of complement C3 
     Nonimmune serum factors: transferins bind
iron                        
          Stealth Microbe siderophores sequester iron  
     Lactobacillus produces potent S.M.  growth
inhibitor                 
 
MORE ON Stealth Microbe PROTEINASE  
     Cleavage of immunoglobulins including
IgA                             
      FC Portion of immunoglobulin g
degraded                               
     REDUCED BACTERICIDAL ACTIVITY AGAINST ESCHERICHIA
         
COLI                                                             
     Alpha 2 macroglobulin & alpha 1
proteinase                            

MORE ON MANNANS AND POLYSACCHARIDES 
     Multiple inhibition of proliferative
response                         
     Mannan inhibits
lymphoproliferation                                   
     Stealth Microbe specific inhibition proliferative
response            
     Glycoprotein & mannan suppress
lymphoproliferation                    
     Mannan increases hydrogen peroxide
production                         
     Polysaccharide antigens inhibit lymphocyte
proliferation              
     Polysaccharide depression of cellular
function                        

MORE ON GLIOTOXIN 
     Gliotoxin present in vaginal
samples                                  
     Cultured cell growth
blocked                                          
     Gliotoxin reduces B lymphocytes
count                                 
     Irradiation increased gliotoxin
toxicity                              
    
Apoptosis                                                             
          DNA fragmentation in macrophages - apoptosis  
          Apoptosis of mouse L929 fibroblast cells 
          Apoptosis in concanavalin a-stimulated t blasts 
          Apoptosis of T blasts and macrophages 
          80-95% inhibition of protein synthesis 
          Lymphoid organ apoptosis 
          Cytoskeletal structure damage & adhesion loss 
          Kills non-hematopoietic cells 
     TISSUE
DAMAGE                                                         
          Extensive tissue damage 
          Cytoskeletal microfilament/detachment/vacuolation 
          Modification of microfilaments or plasma membranes 
               Induction of microvilli loss  
               Reorganization of cortical cytoplasm  
               Altered bile acid uptake   
               Afflux   
               Modified hormone responsiveness  
(Stealth Microbe DIABETES will have much on hormones)
"Incubation of Stealth Microbe cells with human luteinizing hormone
(hLH),
human chorionic gonadotrophin(hCG) Or glucagon  produced a significant
rise in cAMP total levels."

Mice treated with cortisone were susceptible to intratracheal challenge
with
10-100 x less  Stealth Microbe than were untreated mice. 

"Stealth Microbe also possesses enzymes that can reduce steroids at the
3-
,17-and 20-oxo-groups.

          Altered morphology and plasma membrane function 
          Tumor-like lesions on major organs  

     DNA
CHANGES                                                           
          Drastic DNA changes & precancerous tissue damage 
          Raised inositol triphosphate & DNA fragmentation 
          30 ng/ml prevents T & B cell DNA synthesis 
          DNA fragmentation of T and B cells 
               Genome severely damaged  
               Alloreactive cytotoxic T cells  
     DAMAGE BELOW THE GENERALIZED TOXICITY
THRESHOLD                       
          Significant DNA damage in thymocytes at  um  
          Glucose metabolism selectively affected 
          Macromolecular synthesis selectively affected 
          Basal rate of H2O2 production inhibited 
          Macrophage activity abrogated 
    
LYMPHOPROLIFERATION                                                   
          T-cell proliferation inhibition 
          Mitogen or interleukin induced b & t proliferation 
          Leukocytes as stimulator cells disabled 
          Depletion of murine epidermal Langerhans  
               Major histocompatibility complex   
               (nm) concentration ultrastructural damage to lc   
               Immune response and contact sensitivity   
          Increased suppressor cell activity of B-lymphocytes 
               Phytohemagglutinin-induced mitogen response
                    suppressed  
               Anti-sheep erythrocyte antibody response
                    suppressed  
               Anti-thy 1 antibody and complement    
               Not plastic-adherent or mac-1 antigen-positive    
          Cytotoxic T cells production failure 
    
MACROPHAGES                                                           
          Macrophage phagocytosis irreversibly inhibited  
          Microvilli loss and chromatin condensation 
          In vivo macrophage & T cell dependent mechanisms 
     Stealth Microbe
TOXINS                                                
          High molecular weight toxins 
               Glycoprotein toxins  
               SMtoxin  
          Low molecular-weight toxins 
          Stealth Microbe toxin investigation results 
          Pathogenic enzymes 
               Proteinase  
               Phospholipases  
               Lysophospholipase-transacylase  

WHAT Stealth Microbe IS 
     Stealth Microbe - the most pervasive S.M. pathogen                  
     A facultative pathogen - masquerading
marauder                        
     Pathogenic
trickery                                                   
     Pathogenesis and phenotypic
switching                                 
          Differential expression of virulence factors  
          Rapid alteration of phenotype 
          9 distinct colony phenotypes 
          Colony morphology 
          Constraints on the ___ __ _____ transition 
          Cellular phenotype 
          Patterns of gene expression 
          Resistance to anti-S. M. agents 
          Antigenicity 
     Stealth Microbe has amphotericin b
resistance                         
     Pathologic states are extremely
varied                                
     Invasive potential increases with
quantity                            

MORE ON WHAT Stealth Microbe DOES 
     Gut colony may impair cell mediated
immunity                          
     Stealth Microbe is a cause of
immunodeficiency                        
     Increased susceptibility to bacterial
infection                       
          Suppressed DTH and bacterial sepsis 
          Elevated Stealth Microbe antigen titers & bacterial sepsis 
     World wide plague - often
refractory                                  
     Stealth Microbe infections are increasing in
incidence                

How it isn't detected 
     Molecular
mimicry                                                     
     Antigenic
variability                                                 
     Topographical variation dependent on carbon
source                    
     Diagnostic skin test
failure                                          

How it is diagnosed 
     Successful post autopsy
diagnosis                                     
     Antemortem diagnosis is
difficult                                     
     Clinician's
uncertainty                                               
     Difficulty in differentiation - colony or
invasion                    
     Invasive biopsy
required                                              
     Therapy by
suspicion

From owner-chromosomes@net.bio.net Sun Nov 17 22:00:00 1996
Path: biosci!ihnp4.ucsd.edu!swrinde!news.uh.edu!usenet
From: hua <hua@uh.edu>
Newsgroups: bionet.genome.chromosomes
Subject: OFR repetitive sequence
Date: 18 Nov 1996 18:23:42 GMT
Organization: uh/biol. dept.
Lines: 3
Message-ID: <56q9je$kos@Masala.CC.UH.EDU>
NNTP-Posting-Host: wimp.nsm.uh.edu
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.1N (Macintosh; I; 68K)
X-URL: news:bionet.genome.chromosomes

Please help!!! What is OFR repetitive sequence?



From owner-chromosomes@net.bio.net Mon Nov 18 22:00:00 1996
Path: biosci!ihnp4.ucsd.edu!swrinde!howland.erols.net!feed1.news.erols.com!phase2.worldnet.att.net!netnews.worldnet.att.net!uunet!in3.uu.net!wizard.pn.com!news.xensei.com!news
From: symposia@xensei.com (Cambridge Symposia)
Newsgroups: bionet.genome.chromosomes
Subject: 1997 Cambridge Symposia Spring Conferences
Date: Tue, 19 Nov 1996 14:37:51 GMT
Organization: Cambridge Symposia
Lines: 63
Message-ID: <56sgvh$erq@xensei3.xensei.com>
Reply-To: symposia@xensei.com
NNTP-Posting-Host: chi.xensei.com
X-Newsreader: Forte Free Agent 1.0.82

If you wish to receive information about the conferences list below,
please contact:

Cambridge Symposia
1037 Chestnut Street
Newton Upper Falls,  MA  02164
USA

Phone: 617-630-1399
Fax: 617-630-1395
E-mail: symposia@cambridge.org
http://www.cambridge.org/symposia/



EMERGING CLINICAL APPLICATIONS OF FIBRIN SEALANT 
Organizers: William Drohan-American Red Cross, Martin MacPhee-American
                   Red Cross, Uri Martinowitz-National  Hemophilia
                   Center, Michael O'Leary-U.S. Navy Marine Corps.,
                   and Tom Lynch-Food and Drug Administration
March 7-10, 1997  San Diego, California 

GENETIC APPROACHES TO BREAST AND PROSTATE CANCER 
 Organizers: Marc E. Lippman-Georgetown University, Robert B.
                    Dickson-Georgetown University, and  John T. 
                    Isaacs-Johns Hopkins University
March 22-28, 1997   Lake Tahoe, California 

UNSTABLE TRIPLETS, MICROSATELLITES, AND HUMAN DISEASE 
 Organizers: Jack Griffith-University North Carolina-Chapel Hill,
                   Robert Wells-Texas A&M University, and David 
                   Nelson-Baylor College of Medicine
March 31-April 6, 1997   Santa Fe, New Mexico 

TNF-alpha ANTAGONISTS: MONOCLONAL ANTIBODIES, SOLUBLE 
RECEPTORS, THALIDOMIDE AND OTHER NOVEL APPROACHES 
Organizers: Gilla Kaplan-Rockefeller University,  Carol A. Nacy-Entre 
                  Med, Inc., and Victoria Freedman-Rockefeller 
                 University
April 13-18, 1997   Santa Fe, New Mexico 

NUCLEAR STRUCTURE-GENE EXPRESSION INTERRELATIONSHIPS 
Organizers: Gary Stein-University of Massachusetts Medical Center,  
                  Gordon  Hager-National Institutes of Health, 
                  and Ronald Berezney-SUNY-Buffalo
May 16-22, 1997  Bolton Valley, Vermont 

ADVANCES IN CONGESTIVE HEART FAILURE, RESEARCH AND THERAPEUTICS 
Organizers: Giora Feuerstein-SmithKline Beecham Pharmaceuticals and
                   Michael Fowler-Stanford University School of
                   Medicine
 May 27-31, 1997  Lake Tahoe, California 


1997 Nature America Conference Administerd by Cambridge Symposia

The Fifth International Nature Genetics' conference entitled:
FUNCTIONAL GENOMICS: From Genes to Drugs 
 Washington Court Hotel, Washington, D.C. April 17-18, 1997

ANTISENSE 97: Targeting the Molecular Basis of Disease
Hyatt Regency, Cambridge, MA., May 1-2, 1997


From owner-chromosomes@net.bio.net Wed Nov 20 22:00:00 1996
Newsgroups: bionet.genome.chromosomes
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.erols.net!EU.net!usenet2.news.uk.psi.net!uknet!usenet1.news.uk.psi.net!uknet!uknet!strath-cs!bradford.ac.uk!leeds.ac.uk!news
From: RMRHCA@leeds.ac.uk (Helen Ardley)
Subject: chromosome 19 mapping
Message-ID: <571f4n$7u8_003@leeds.ac.uk>
NNTP-Posting-Host: sjuh_pc41.leeds.ac.uk
Organization: University of Leeds
Date: Thu, 21 Nov 1996 11:41:18 +0000 (GMT)
X-Newsreader: News Xpress Version 1.0 Beta #4
Lines: 4

Does anyone know of a chromosome 19 deletion mapping panel?
Thanks for any help.
Helen Ardley
rmrhca@stjames.leeds.ac.uk

From owner-chromosomes@net.bio.net Wed Nov 20 22:00:00 1996
Path: biosci!rutgers!uwm.edu!news-peer.gsl.net!news.gsl.net!hunter.premier.net!feed1.news.erols.com!phase2.worldnet.att.net!netnews.worldnet.att.net!uunet!in3.uu.net!news.u.washington.edu!roach
From: roach@u.washington.edu (Jared Roach)
Newsgroups: bionet.genome.chromosomes
Subject: One Percent of the Human Genome Sequenced.
Date: 21 Nov 1996 03:40:27 GMT
Organization: University of Washington, Seattle
Lines: 13
Message-ID: <570ivb$pe4@nntp3.u.washington.edu>
NNTP-Posting-Host: saul3.u.washington.edu
NNTP-Posting-User: roach

	One percent of the human genome has been sequenced.  I have
updated my "How Much of the Human Genome Has Been Sequenced?" web
page to reflect this.  The provisional figure that I had on my page 
for the last two weeks was in error and has been corrected.

The web page is located at:

http://weber.u.washington.edu/~roach/human_genome_progress2.html



					Best Wishes to All,
							Jared

From owner-chromosomes@net.bio.net Sun Nov 24 22:00:00 1996
Path: biosci!agate!howland.erols.net!news.sgi.com!mr.net!newshub.tc.umn.edu!fu-berlin.de!news.belwue.de!news.uni-ulm.de!rz.uni-karlsruhe.de!news.fzk.de!usenet
From: j.ludat@hvt.fzk.de (Juergen Ludat)
Newsgroups: bionet.genome.chromosomes
Subject: CHROMOSOME 18
Date: 25 Nov 1996 16:11:07 GMT
Organization: Forschungszentrum Karlsruhe, Germany
Lines: 8
Distribution: world
Message-ID: <57cger$fjf@hdihp3.fzk.de>
NNTP-Posting-Host: 141.52.137.71
Mime-Version: 1.0
Content-Type: Text/Plain; charset=US-ASCII
X-Newsreader: WinVN 0.99.6

Hello,
can anyone give me some information about chromosome 18 defects, especially
about the 18 p defekt.
A nephews child is born with that defect and the parents want to know all, what 
is worth knowing.
thank you for answer
juergen


From owner-chromosomes@net.bio.net Mon Nov 25 22:00:00 1996
Path: biosci!fcs280s.ncifcrf.gov!cpk-news-feed1.bbnplanet.com!news.bbnplanet.com!cam-news-hub1.bbnplanet.com!uunet!in2.uu.net!ott.istar!istar.net!tor.istar!east.istar!news
From: Stephanie St-Pierre <stpierre@nt.net>
Newsgroups: bionet.genome.chromosomes
Subject: 11:22 translocation
Date: 26 Nov 1996 17:19:10 GMT
Organization: International 11;22 Translocation Network
Lines: 12
Message-ID: <57f8qe$jh7@nr1.toronto.istar.net>
NNTP-Posting-Host: timmins-115.nt.net
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 2.01KIT (Win16; U)

Hi there:

I'm the mother of a 20 month old girl affected by unbalanced 11;22 
translocation, also called partial trisomy 11;22 or trisomy 22. I am 
always looking for other families who have children with this disorder to 
correspond with, so we can share information and progress.

I'd love to hear from anyone out there.

Stephanie
stpierre@nt.net


From owner-chromosomes@net.bio.net Tue Nov 26 22:00:00 1996
Path: biosci!CHI1.UNCFSU.EDU!fwaddle
From: fwaddle@CHI1.UNCFSU.EDU (Floyd Waddle)
Newsgroups: bionet.genome.chromosomes
Subject: chromosome fusions/fissions
Date: 27 Nov 1996 07:53:15 -0800
Organization: Fayetteville State University
Lines: 35
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <329C8DF7.14C@chi1.uncfsu.edu>
NNTP-Posting-Host: net.bio.net

As described in the textbooks, Robertsonian fusions are produced by the 
replacement of the short arm of one acrocentric with the long arm of 
another acrocentric.  In centric fusions, breaks occur at the centromeres 
of two acrocentrics and the portions of each centromere which carry the 
long arms are fused together.

All genetics textbooks I have seen describe one or the other of these two 
types of fusion.  The idiograms for human and chimp, however, show an 
entirely different type of fusion.  The human second chromosome was 
produced by breakage at the tips of two short arms with the subsequent 
fusion of the short arms.  The result was a dicentric chromosome in which 
one of the centromeres became suppressed.  Amazingly, I have a textbook 
in which the text describes the fusion as a centric fusion while the 
accompanying figure clearly shows short arm fusion.

Thus, I have two questions:
  1.  Why did the author misidentify the type of fusion even though he 
could see that he was wrong just by reading his own book?
  2.  I have not seen idiograms of species other than those of humans and 
apes.  The karyotypes easily available to me do not show the detail 
necessary to distinguish one chromosome type fusion from another.  Thus, 
I have not seen proof of either Robersonian fusions or centric fusions.  
The textbooks do not give references that I can look up.  Is there any 
literature that demonstrates the reality of either Robersonian or centric 
fusion, or are they merely figments of the collective imagination of 
textbook writers?

Chromosome fisions are also described in the textbooks but the authors do 
not explain where the telemeres come from which are necessary to close 
off the raw ends of the fissioned chromosomes.  Have fissions actually 
been demonstrated or are the textbook writers postulating them merely 
because they can think of no other method of evolution for mammals with 
large chromosome numbers?

Floyd Waddle

From owner-chromosomes@net.bio.net Tue Nov 26 22:00:00 1996
Path: biosci!internet!biosci!not-for-mail
From: biohelp (BIOSCI Administrator)
Newsgroups: bionet.genome.chromosomes
Subject: BIOSCI/bionet miniFAQ & Fundraiser
Date: 27 Nov 1996 02:00:45 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 239
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199611271000.CAA04400@net.bio.net>
NNTP-Posting-Host: net.bio.net

(LAST REVISION: 30-JUL-95)

This BIOSCI "miniFAQ" is designed to answer the questions that come up
the *most frequently*.  The main BIOSCI FAQ (Frequently Asked
Questions) is accessible on the World Wide Web at URL
http://www.bio.net/.

If you can not find an answer to your question in this or other
documentation, the BIOSCI technical support staff answers e-mail
queries sent to

		       biosci-help@net.bio.net

We can only answer questions about the use of the newsgroups and
mailing lists.  We unfortunately do not have the staff to do Internet
information searches or answer scientific questions.  Please post
those to the appropriate BIOSCI/bionet newsgroups.


	Contents:
	--------
	0) BIOSCI NEEDS YOUR SUPPORT!!

	1) Using the WWW to access the BIOSCI/bionet newsgroups.

	2) What to do about "spams," i.e., junk mail, ads, etc.

	3) Examples of subscribing and unsubscribing to the mailing lists.

	4) The BIOSCI user address and research interest directory.


0) BIOSCI NEEDS YOUR SUPPORT!!
------------------------------
BIOSCI's government funding has been expended, and we are now
operating solely from advertising revenue that we have raised from our
Web site at http://www.bio.net/.  We need just a few minutes of your
time to help us serve you.

You can do two important things which will take very little time for
you individually and will immensely help us continue to help you.

First, please use our WWW system at http://www.bio.net/ to access the
archives.  You can post or reply to messages via your Web browser as
described in item #1 below.  Your usage helps attract sponsors. If you
contact any of our sponsors, please be sure to thank them for
supporting BIOSCI. It is critical for them to get this feedback if
they are to continue their sponsorship for the long term.

Second, if you work for a company or organization that provides
products or services of interest to the biology community, please pass
this message on to your marketing or marketing communications
department or other appropriate group.  Please ask them to help
support BIOSCI by sponsoring our Web site and explain the uses and
benefits of the system to the biology community. If they are
interested, they can then contact us for further information at our
tech support address, biosci-help@net.bio.net.


1) Using the WWW to access the BIOSCI/bionet newsgroups.
--------------------------------------------------------
As of 10 December 1995, all BIOSCI/bionet full newsgroups are
accessible through the World Wide Web (WWW) at URL http://www.bio.net.
One can read and reply publicly or privately to both recent postings
and archived messages through one's Web browser if it is configured
properly to send e-mail.  Each newsgroup is equipped with its own WAIS
index.  The main BIOSCI home page also has access to the BIO-JOURNALS
Table of Contents database WAIS index and the BIOSCI user address
database described in another item further below.


2) What to do about "spams," i.e., junk mail, ads, etc.
-------------------------------------------------------
BIOSCI is a set of parallel USENET newsgroups (the "bionet" groups),
mailing lists, and a hypermail archive at URL http://www.bio.net/.
The same postings are distributed on all media (except for a small
number of mailing-list-only groups at net.bio.net).  Unfortunately it
is becoming a despicable practice on the Internet (by a few people out
to make a fast buck) to do automated mass postings to thousands of
newsgroups and mailing lists.  These attempts to grab free advertising
are refered to as "spams" in the usual, somewhat boneheaded, net
terminology.  USENET is more susceptible to this practice, and many
spams originate on the USENET groups and then are passed on to the
mailing lists.  However, spammers also get lists of mailing addresses
and hit these too, so neither medium is immune.

What should you do personally if you get junk mail?
---------------------------------------------------
Just delete it and move on without reading it further.  Filing a
protest is becoming increasingly useless because spammers are often
disguising the addresses where the messages are sent from.  Unless you
really understand Internet mail systems, your attempt at protest by
sending replies to the message will often end up being sent to the
address of an innocent person that the spammer is victimizing.

What can BIOSCI/bionet do to protect its newsgroups?
----------------------------------------------------
The only solution currently available is to moderate the newsgroup.
If this newsgroup is already moderated, then you are in good shape.
Moderation protects the USENET distribution from about 95% of the
spams that are being sent to date and protects the mailing lists
completely.  Moderation means, however, that someone has to take the
time to review each message before it goes out.  We have set up
software here that simply allows the moderator to forward to an
address at net.bio.net messages that (s)he wishes to have distributed.
This takes no more time than that needed to read the message and pass
it on, say about 1 min. per message.

Most newsgroups currently have a discussion leader who is responsible
for their newsgroup.  The discussions leaders and their e-mail
addresses are listed in the BIOSCI Information Sheet which is
available on the Web at http://www.bio.net/.  If a newsgroup is being
hit with too many junk postings, please contact the discussion leader
for that group and see if there is interest in moderating the group.
Please do not assume that by simply posting a complaint to the
newsgroup itself, anyone on the BIOSCI staff will act on your
complaint.  With close to 100 newsgroups to run, the BIOSCI staff has
to rely on the discussion leaders of each newsgroup to report problems
directly to us at biosci-help@net.bio.net.

We will moderate any of our newsgroups if the discussion leader tells
us that the readership of the group wishes to do so and if a moderator
is willing to do the work.  For most BIOSCI/bionet groups, this
entails only a few minutes of work each day.

Moderating a newsgroup will resolve probably 95% of the junk postings
on the USENET distribution.  Unfortunately there are easy ways for
determined spammers to override the moderation mechanism on USENET,
but we can protect our e-mail subscribers from unwanted postings if
the newsgroup is moderated.  You can also access our newsgroups over
the WWW at URL http://www.bio.net.  While this Web interface will not
stop spammers from trying to post to the groups, this will give you
yet another way, besides using USENET news, to keep the junk out of
your personal mail files.  For those of you with local USENET news
systems, the Web interface will also give you faster access to new
newsgroups and recent postings.


3) Examples of subscribing and unsubscribing to the mailing lists.
------------------------------------------------------------------
PLEASE NOTE: The BIOSCI management does NOT act on
subscription/unsubscription requests that are posted improperly to the
newsgroups and mailing lists.  People who do this only bother everyone
on the lists to no avail.  Please be sure to follow the proper
procedures below.

Gory details are in the BIOSCI Information sheets on the Web at
http://www.bio.net.  Below we give an example utilizing the
METHODS-AND-REAGENTS list at both of our two BIOSCI sites:

Users in the Americas and Pacific Rim countries who use the BIOSCI
------------------------------------------------------------------
node at computer net.bio.net:
----------------------------

A) Determine the "listname" which is the <=8 character mail address
                                         ^^^^^^^^^^^^^
   for the group.  These can be found in the BIOSCI Info. Sheet.  For
   the METHODS-AND-REAGENTS group the mailing address is
   methods@net.bio.net.  The listname is the portion of the address to
   the left of the @ sign, i.e., "methods".  The listname is used with
   the "subscribe" and "unsubscribe" commands illustrated below.

B) Mail all commands in the body of a mail message addressed to
   biosci-server@net.bio.net.  Do NOT send commands to the newsgroup
   posting addresses!  Leave the Subject: line blank, any text on it
   will be ignored.

C) In the body of your message put one or more of the following
   commands with an "end" command on the last line, e.g.,

   subscribe methods
   unsubscribe methods
   end

   Do NOT put your e-mail address or other text on these lines.  The
   server only allows you to cancel your subscription if the address
   on your mail header matches the address on our mailing list.
   Please ask for help at biosci-help@net.bio.net if your address has
   changed, e.g., if you know you are on the list but the server tells
   you that you are not a member.


Users in Europe, Africa, and Central Asia who use the BIOSCI node at
--------------------------------------------------------------------
computer daresbury.ac.uk (also known as dl.ac.uk):
-------------------------------------------------

To subscribe and unsubscribe to/from the BIOSCI lists, you need to
specify the full USENET newsgroup name with "bionet-news." prepended.
The USENET newsgroup names are listed in the BIOSCI Information sheet
on the Web at http://www.bio.net/.  For the METHODS-AND-REAGENTS list
the USENET newsgroup name is bionet.molbio.methds-reagnts, thus the
appropriate commands are

    sub bionet-news.bionet.molbio.methds-reagnts

    unsub bionet-news.bionet.molbio.methds-reagnts

These commands are included in a message addressed to mxt@dl.ac.uk,
NOT to the newsgroup mailing addresses.  As usual, include the text in
the body of the message as text on the Subject: line is ignored.

To unsubscribe from all the lists at the UK node, use

    unsub bionet-news

Please note that if the address in the list is different than the one
in your mail message header, you will not be able to unsubscribe by
this method. If you have problems, please mail biosci@daresbury.ac.uk.


4) The BIOSCI user address and research interest directory.
-----------------------------------------------------------
Please take this opportunity to add your name, address, and research
interest information to the BIOSCI User Address Database if you have
not already done so.

You can fill out the address form directly through our Web page at URL
http://www.bio.net/adrform.html.

The address database is reindexed nightly for WWW access (the URL is
http://www.bio.net/).  If you are not directly on the Internet but can
reach it by e-mail, please use our waismail server to access the user
directory.  waismail use is described above.  You can also request a
user address form by e-mail from biosci-help@net.bio.net.

Please check your database entry from time-to-time to see if your
address information is still up-to-date.  Because of our limited
personnel resources, we ask that you resubmit a *complete* form to
revise your entry; we only replace complete entries and do not have
resources to edit old forms.

				Sincerely,

				Dave Kristofferson
				BIOSCI/bionet Manager

				biosci-help@net.bio.net

From owner-chromosomes@net.bio.net Wed Nov 27 22:00:00 1996
Path: biosci!agate!howland.erols.net!news-peer.gsl.net!news.gsl.net!usenet.eel.ufl.edu!warwick!lyra.csx.cam.ac.uk!daresbury!not-for-mail
From: "Johan van Ooijen (+31) 317 477 319" <J.W.VANOOIJEN@cpro.dlo.nl>
Newsgroups: bionet.genome.chromosomes
Subject: JoinMap & MapQTL software announcement
Date: 28 Nov 1996 14:33:38 -0000
Lines: 32
Sender: lpddist@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <57k7s2$bth@mserv1.dl.ac.uk>
Autoforwarded: false
Ua-Content-Id: 11ABE3E12B00
Hop-Count: 4
Importance: normal
Disclose-Recipients: prohibited
Original-To: biochrom@dl.ac.uk

You can now read about the genetic mapping software packages JoinMap and 
MapQTL on the web site of CPRO-DLO:
   http://www.bib.wau.nl/cpro/mapping/

Information is presented on the things you can do with these software 
packages. You can also view the manuals to study the details, and you 
can view the lists of frequently asked questions. You can read about 
the computer platforms for which the software is available, how the 
licensing works, what it costs, and how to order.

JoinMap is software for the calculation of genetic linkage maps. It 
handles data from all kinds of full-sib families (BC, F2, RILs, 
[doubled] haploids, cross-pollinator-progeny), and can combine data 
from several sources into an integrated map. Besides the modules for 
map calculation, the package has some diagnostical modules.

MapQTL is software for the mapping of quantitative trait loci (QTLs). 
It handles data from single full-sib families of all kinds (BC, F2, 
RILs, [doubled] haploids, cross-pollinator-progeny). Used techniques: 
interval mapping, multiple QTL models with cofactors (MQM mapping), 
nonparametric Kruskal-Wallis analysis per marker.

Johan van Ooijen

email:  J.W.vanOoijen@CPRO.DLO.NL  or  mapping@CPRO.DLO.NL
fax:  +31 317 418 094
mail:  CPRO-DLO, POBox 16, 6700 AA Wageningen, the Netherlands

DLO Centre for Plant Breeding and Reproduction Research (CPRO-DLO)

WWW:  http://www.bib.wau.nl/cpro/


From owner-chromosomes@net.bio.net Wed Nov 27 22:00:00 1996
Path: biosci!FMI.CH!plikat
From: plikat@FMI.CH (Uwe Plikat)
Newsgroups: bionet.genome.chromosomes
Subject: mapping software
Date: 28 Nov 1996 04:43:01 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 15
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <329D9705.255A@fmi.ch>
Reply-To: plikat@fmi.ch
NNTP-Posting-Host: net.bio.net

I am urgently looking for mapping software that can build up contigs.

I am mapping a bacterial genome which is stored in a cosmid library 
(taking single cosmids as probes). Anyone any hint?

Thanks,

Uwe.     
______________________

Uwe Plikat, Ph.D.
Phone   +41-61-6966442
Fax	    +41-61-6966323
email			plikat@fmi.ch
______________________

From owner-chromosomes@net.bio.net Thu Nov 28 22:00:00 1996
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.erols.net!portc02.blue.aol.com!audrey01.news.aol.com!not-for-mail
From: lmgoin@aol.com
Newsgroups: bionet.genome.chromosomes
Subject: Re: --> Cancer, Stealth Microbe
Date: 29 Nov 1996 22:59:10 GMT
Organization: AOL http://www.aol.com
Lines: 10
Message-ID: <19961129230000.SAA13898@ladder01.news.aol.com>
References: <328FE480.3623@nol.net>
NNTP-Posting-Host: ladder01.news.aol.com
X-Admin: news@aol.com

Hello GQuest;

Am looking for information on Cowden's Disease.  This is a rare genetic
disorder which affects the senses and the growth of brain cells, I think. 
If there is any information you can share on this, please let me know.  If
you know of a web site where I may find some more information on this
topic, please let me know.  
Your wisdom and experience are appreciated.
Thank you,
lmgoin@aol.com

From owner-chromosomes@net.bio.net Thu Nov 28 22:00:00 1996
Path: biosci!rutgers!uwm.edu!cs.utexas.edu!swrinde!news.sgi.com!news.bbnplanet.com!su-news-hub1.bbnplanet.com!arclight.uoregon.edu!phase2.worldnet.att.net!news.u.washington.edu!root
From: "Peter J. Myler" <mylerpj@u.washington.edu>
Newsgroups: bionet.genome.chromosomes
Subject: Re: mapping software
Date: 29 Nov 1996 17:16:32 GMT
Organization: SBRI
Lines: 79
Message-ID: <01bbde19$9e8b5260$39b58e8c@mylerpj>
References: <329D9705.255A@fmi.ch>
NNTP-Posting-Host: cs116-3.u.washington.edu
Mime-Version: 1.0
Content-Type: multipart/alternative; boundary="----=_NextPart_000_01BBDDD6.90713A20"
Content-Transfer-Encoding: 7bit
X-Newsreader: Microsoft Internet News 4.70.1155

This is a multi-part message in MIME format.

------=_NextPart_000_01BBDDD6.90713A20
Content-Type: text/plain; charset=ISO-8859-1
Content-Transfer-Encoding: 7bit

Uwe:

You might want to try SEGMAP, developed by Phil Green and Chuck Magness. 
You can get it from Chuck at cmagness@u.washington.edu.

Peter
-- 
=====================================================
Peter J. Myler
Seattle Biomedical Research Institute
4 Nickerson Street
Seattle, WA  98109-1651
phone: (206) 284-8846x332
FAX: (206) 284-0313
e-mail: MYLERPJ@U.WASHINGTON.EDU
=====================================================





Uwe Plikat <plikat@FMI.CH> wrote in article <329D9705.255A@fmi.ch>...
> I am urgently looking for mapping software that can build up contigs.
> 
> I am mapping a bacterial genome which is stored in a cosmid library 
> (taking single cosmids as probes). Anyone any hint?
> 
> Thanks,
> 
> Uwe.     
> ______________________
> 
> Uwe Plikat, Ph.D.
> Phone   +41-61-6966442
> Fax	    +41-61-6966323
> email			plikat@fmi.ch
> ______________________
> 
------=_NextPart_000_01BBDDD6.90713A20
Content-Type: text/html; charset=ISO-8859-1
Content-Transfer-Encoding: quoted-printable

<html><head></head><BODY bgcolor=3D"#FFFFFF"><p><font size=3D2 =
color=3D"#000000" face=3D"Arial">Uwe:<br><br>You might want to try =
SEGMAP, developed by Phil Green and Chuck Magness. &nbsp;You can get it =
from Chuck at cmagness@u.washington.edu.<br><br>Peter<br>-- =
<br>=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D<br>Peter J. Myler<br>Seattle Biomedical Research =
Institute<br>4 Nickerson Street<br>Seattle, WA =
&nbsp;98109-1651<br>phone: (206) 284-8846x332<br>FAX: (206) =
284-0313<br>e-mail: <font =
color=3D"#0000FF"><u>MYLERPJ@U.WASHINGTON.EDU</u><font =
color=3D"#000000"><br>=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D<br><br><br><br><br><br>Uwe Plikat =
&lt;<font color=3D"#0000FF"><u>plikat@FMI.CH</u><font =
color=3D"#000000">&gt; wrote in article &lt;<font =
color=3D"#0000FF"><u>329D9705.255A@fmi.ch</u><font =
color=3D"#000000">&gt;...<br>&gt; I am urgently looking for mapping =
software that can build up contigs.<br>&gt; <br>&gt; I am mapping a =
bacterial genome which is stored in a cosmid library <br>&gt; (taking =
single cosmids as probes). Anyone any hint?<br>&gt; <br>&gt; =
Thanks,<br>&gt; <br>&gt; Uwe. &nbsp;&nbsp;&nbsp;&nbsp;<br>&gt; =
______________________<br>&gt; <br>&gt; Uwe Plikat, Ph.D.<br>&gt; Phone =
&nbsp;&nbsp;+41-61-6966442<br>&gt; Fax&#009; =
&nbsp;&nbsp;&nbsp;+41-61-6966323<br>&gt; email&#009;&#009;&#009;<font =
color=3D"#0000FF"><u>plikat@fmi.ch</u><font color=3D"#000000"><br>&gt; =
______________________<br>&gt; </p>
</font></font></font></font></font></font></font></font></font></body></h=
tml>
------=_NextPart_000_01BBDDD6.90713A20--


